gene-filtering-by-expression-level
Summary
Filter a gene expression matrix to retain only the highest-expressed genes by mean expression rank, reducing dimensionality while preserving the most informative signal for downstream pathway enrichment analysis. This pre-processing step improves computational efficiency and can preserve pathway enrichment results across different matrix dimensionalities.
When to use
Apply this skill when you have a large gene expression matrix (e.g., thousands of genes) from normalized microarray or RNA-seq data and need to reduce computational burden before running pathway enrichment analysis (e.g., GSEA or GESECA). Use it particularly when validating whether dimensionality reduction preserves pathway scores and p-values, or when working with memory-constrained systems.
When NOT to use
- Input is already a pre-filtered or curated feature table (e.g., a manually selected pathway gene set).
- Analysis requires detection of rare transcripts or lowly-expressed disease-associated genes that fall below the expression threshold.
- You need to preserve all genes for variance-stabilizing normalization or for building a background distribution for statistical testing.
Inputs
- normalized gene expression matrix (genes × samples)
- normalized expression values (log2 and quantile-normalized)
- integer threshold for top-N genes to retain
Outputs
- filtered gene expression matrix (subset of top genes × samples)
- subset of gene identifiers retained after filtering
How to apply
After log2 and quantile normalization of the expression matrix using limma::normalizeBetweenArrays(), calculate the mean expression level for each gene (row-wise mean). Rank genes by descending mean expression and subset to retain the top N genes (e.g., 12,000 genes in the referenced study). The rationale is that lowly-expressed genes contribute noise rather than signal to pathway enrichment; filtering to highly-expressed genes reduces the input dimensionality while maintaining correlation of pathway p-values (≥0.95 Pearson correlation of log10-transformed p-values) between full and reduced matrices, demonstrating negligible information loss for downstream analysis.
Related tools
- limma (Apply log2 and quantile normalization to expression matrix before filtering)
- fgsea (Perform pathway enrichment analysis on filtered matrix and validate score/p-value preservation) — https://github.com/ctlab/fgsea
- R base functions (Calculate rowMeans() for mean expression per gene and order() to rank genes)
- ggplot2 (Visualize correlation of log10 p-values between full and reduced matrices)
Examples
es <- es[head(order(rowMeans(exprs(es)), decreasing=TRUE), 12000), ]
Evaluation signals
- Verify that the number of retained genes equals the specified threshold (e.g., 12,000).
- Confirm that retained genes have non-zero mean expression and are ranked in descending order of mean expression.
- Compute Pearson correlation of log10-transformed pathway p-values from GESECA analysis on full vs. filtered matrices and confirm ≥0.95 correlation, indicating preservation of pathway enrichment signal.
- Check that filtering reduces matrix memory footprint and improves computational runtime for downstream GSEA/GESECA without substantial loss of significance rankings.
- Validate that gene identifiers in filtered matrix match the original annotation (no duplicates, no 'empty' or '///' identifiers)
Limitations
- Filtering by mean expression alone may inadvertently remove genes with strong but context-specific (e.g., time-point or condition-dependent) expression patterns.
- The optimal threshold (e.g., 12,000 genes) is data-dependent and may not generalize across different tissues, platforms, or sample sizes.
- Filtering is performed after normalization; biases introduced during normalization (e.g., platform batch effects) are not corrected by this step alone.
- The skill assumes that lowly-expressed genes contribute primarily noise to pathway enrichment; this assumption may not hold for rare cell populations or rare transcript detection.
Evidence
- [methods] Filter to top genes by mean expression: "es <- es[head(order(rowMeans(exprs(es)), decreasing=TRUE), 12000), ]"
- [methods] Filtering preserves pathway enrichment signal across dimensionalities: "apply log2 and quantile normalization using limma::normalizeBetweenArrays, filter to top 12,000 genes by mean expression"
- [methods] Validation threshold for filtering effectiveness: "confirm that Pearson correlation of log10 p-values between full and reduced results is ≥0.95, indicating negligible information loss from dimensionality reduction"
- [other] Rationale: fgsea enables comparison across dimensionalities: "fgsea enables fast and accurate calculation of GSEA P-values for gene set collections, supporting the feasibility of comparing pathway enrichment results across different input dimensionalities"
1---2name: gene-filtering-by-expression-level3description: Use when you have a large gene expression matrix (e.g., thousands of genes) from normalized microarray or RNA-seq data and need to reduce computational burden before running pathway enrichment analysis (e.g., GSEA or GESECA).4license: CC-BY-4.05---67# gene-filtering-by-expression-level89## Summary1011Filter a gene expression matrix to retain only the highest-expressed genes by mean expression rank, reducing dimensionality while preserving the most informative signal for downstream pathway enrichment analysis. This pre-processing step improves computational efficiency and can preserve pathway enrichment results across different matrix dimensionalities.1213## When to use1415Apply this skill when you have a large gene expression matrix (e.g., thousands of genes) from normalized microarray or RNA-seq data and need to reduce computational burden before running pathway enrichment analysis (e.g., GSEA or GESECA). Use it particularly when validating whether dimensionality reduction preserves pathway scores and p-values, or when working with memory-constrained systems.1617## When NOT to use1819- Input is already a pre-filtered or curated feature table (e.g., a manually selected pathway gene set).20- Analysis requires detection of rare transcripts or lowly-expressed disease-associated genes that fall below the expression threshold.21- You need to preserve all genes for variance-stabilizing normalization or for building a background distribution for statistical testing.2223## Inputs2425- normalized gene expression matrix (genes × samples)26- normalized expression values (log2 and quantile-normalized)27- integer threshold for top-N genes to retain2829## Outputs3031- filtered gene expression matrix (subset of top genes × samples)32- subset of gene identifiers retained after filtering3334## How to apply3536After log2 and quantile normalization of the expression matrix using limma::normalizeBetweenArrays(), calculate the mean expression level for each gene (row-wise mean). Rank genes by descending mean expression and subset to retain the top N genes (e.g., 12,000 genes in the referenced study). The rationale is that lowly-expressed genes contribute noise rather than signal to pathway enrichment; filtering to highly-expressed genes reduces the input dimensionality while maintaining correlation of pathway p-values (≥0.95 Pearson correlation of log10-transformed p-values) between full and reduced matrices, demonstrating negligible information loss for downstream analysis.3738## Related tools3940- **limma** (Apply log2 and quantile normalization to expression matrix before filtering)41- **fgsea** (Perform pathway enrichment analysis on filtered matrix and validate score/p-value preservation) — https://github.com/ctlab/fgsea42- **R base functions** (Calculate rowMeans() for mean expression per gene and order() to rank genes)43- **ggplot2** (Visualize correlation of log10 p-values between full and reduced matrices)4445## Examples4647```48es <- es[head(order(rowMeans(exprs(es)), decreasing=TRUE), 12000), ]49```5051## Evaluation signals5253- Verify that the number of retained genes equals the specified threshold (e.g., 12,000).54- Confirm that retained genes have non-zero mean expression and are ranked in descending order of mean expression.55- Compute Pearson correlation of log10-transformed pathway p-values from GESECA analysis on full vs. filtered matrices and confirm ≥0.95 correlation, indicating preservation of pathway enrichment signal.56- Check that filtering reduces matrix memory footprint and improves computational runtime for downstream GSEA/GESECA without substantial loss of significance rankings.57- Validate that gene identifiers in filtered matrix match the original annotation (no duplicates, no 'empty' or '///' identifiers)5859## Limitations6061- Filtering by mean expression alone may inadvertently remove genes with strong but context-specific (e.g., time-point or condition-dependent) expression patterns.62- The optimal threshold (e.g., 12,000 genes) is data-dependent and may not generalize across different tissues, platforms, or sample sizes.63- Filtering is performed after normalization; biases introduced during normalization (e.g., platform batch effects) are not corrected by this step alone.64- The skill assumes that lowly-expressed genes contribute primarily noise to pathway enrichment; this assumption may not hold for rare cell populations or rare transcript detection.6566## Evidence6768- [methods] Filter to top genes by mean expression: "es <- es[head(order(rowMeans(exprs(es)), decreasing=TRUE), 12000), ]"69- [methods] Filtering preserves pathway enrichment signal across dimensionalities: "apply log2 and quantile normalization using limma::normalizeBetweenArrays, filter to top 12,000 genes by mean expression"70- [methods] Validation threshold for filtering effectiveness: "confirm that Pearson correlation of log10 p-values between full and reduced results is ≥0.95, indicating negligible information loss from dimensionality reduction"71- [other] Rationale: fgsea enables comparison across dimensionalities: "fgsea enables fast and accurate calculation of GSEA P-values for gene set collections, supporting the feasibility of comparing pathway enrichment results across different input dimensionalities"
HolobiomicsLab 